Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies - Wikidata - wikimedia - TriplyDB

Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies

Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies

http://www.wikidata.org/entity/Q28287237

about

Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1 From sirtuin biology to human diseases: an update Alpha-synuclein lipid-dependent membrane binding and translocation through the α-hemolysin channel Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.Chondrocyte-specific pathology during skeletal growth and therapeutics in a murine model of pseudoachondroplasia Neuropathology of synuclein aggregates.Diffuse Lewy body disease.Gamma-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways.Lewy bodies.Enhanced glutamate, IP3 and cAMP activity in the cerebral cortex of unilateral 6-hydroxydopamine induced Parkinson's rats: effect of 5-HT, GABA and bone marrow cell supplementation.The cellular pathology of Parkinson's disease.FAS-dependent cell death in α-synuclein transgenic oligodendrocyte models of multiple system atrophy Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.Parkinson's disease mimicking senile dementia of the Alzheimer type: a clinicopathological study of four autopsy cases.An autopsied case of dementia with Lewy bodies with supranuclear gaze palsy.Biochemical increase in phosphorylated alpha-synuclein precedes histopathology of Lewy-type synucleinopathies SIRT1 protects against α-synuclein aggregation by activating molecular chaperones Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies Propagated but Topologically Distributed Forebrain Neurons Expressing Alpha-Synuclein in Aged Macaques Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson's disease patients.Using leucine zipper to facilitate alpha-synuclein assembly.Interactions between metals and alpha-synuclein--function or artefact?Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation.Transglutaminase activation in neurodegenerative diseases.Dual Functional Small Molecule Probes as Fluorophore and Ligand for Misfolding Proteins Molecular pathology of Lewy body diseases.Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson's disease.Role of epigenetics in Alzheimer's and Parkinson's disease.The role of s-nitrosylation and s-glutathionylation of protein disulphide isomerase in protein misfolding and neurodegeneration.Models of α-synuclein aggregation in Parkinson's disease.Electrochemical analysis of the fibrillation of Parkinson's disease α-synuclein.A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease.C-terminal part of α-synuclein mediates its activity in promoting proliferation of dopaminergic cells.RNA interference mediated silencing of alpha-synuclein in MN9D cells and its effects on cell viability Sensitization of neuronal cells to oxidative stress with mutated human alpha-synuclein.Human beta-synuclein rendered fibrillogenic by designed mutations.Role of cytokines during epileptogenesis and in the transition from the interictal to the ictal state in the epileptic mutant EL mouse.

P2860

Q24321216-39D40057-BD8E-410E-91D9-87602E0AD780 Q24554351-6101EC61-2337-4E09-9287-8C483B678F60 Q24671360-204872A1-0638-4AFF-B59A-014316366289 Q27022606-F12ACE48-B4B1-42B8-ACF6-F346C6675D3E Q30153436-480AAFFD-AA02-4855-9643-14E217706BEA Q33703950-3CCDA45B-AA48-4983-A1C5-394A0CA8A933 Q33821143-E6EC6E60-DA15-4C20-9258-CABE9F707881 Q33957376-A9E54760-C07B-459B-BE3B-6F62B663652B Q34063880-F12EB6EA-15EB-43F6-BB74-E968A9848DAF Q34139335-A4ABA1FA-6C42-40DA-819E-6A9F591E184A Q34478663-9A94F928-B6BB-40B1-9567-6CDB3E6FE93A Q34521827-746AD01B-DF98-4D03-B809-73F49E5B33AB Q34523836-B3E133A1-69A8-4CAC-A94C-C98CD6EBC76E Q34571668-71CA536E-6C9D-4456-A2BE-C690806DD95A Q34648491-A622CCA6-F4BF-4605-B0D2-DB1C0B3CDFD4 Q34698588-489FF50A-F00F-4010-948D-43CB9E108D19 Q35179121-0F2AD0B3-34C1-494A-ACF1-CA20A15B1149 Q35593764-665A4324-4437-40D9-A252-43FA72B97AE2 Q35686386-95E6EC6A-09B7-42B3-8226-414AAFDFADD6 Q35747138-DA83587F-10DB-4085-BD5F-51C4BA6E5223 Q35829548-5D6C8427-64A0-4619-9D13-5949DC23246F Q36197708-DE3850A4-71F0-4BF0-A0A9-FC3C8F47C709 Q36333500-EA48DB0C-0D75-427E-8DEA-939FC3ECCD9A Q36841771-FF9FBD5B-079A-4E93-AAC6-F90D342B6495 Q36872892-CBC408BA-4AEC-4256-A012-640969E5CF6B Q37337917-E7E002E8-A124-40CC-8515-44BE3FBB09E2 Q37352964-D5238EC3-8F0B-4144-AE8A-AC5A70294731 Q37401787-D3E5FD86-60A0-4240-9C79-A5C4330A3C12 Q37462203-2221E683-0948-4EC0-A032-0502B630A28C Q37554972-60848DA9-DCEC-49F1-AFD5-B5016F5DBAAE Q37961788-59ACB274-98E2-435A-B418-CCECE373C968 Q38172144-B05E1891-A6AC-4BE3-A7B3-117592E3465E Q38286574-51E8EC99-B9DA-4F52-96DF-1B743DA57D02 Q39293862-13E417F3-CDBA-44CF-A014-33E307C93711 Q39414467-7CA0404D-1AA3-4111-8D7F-1D529DA27B45 Q39589964-AA2D1E54-AF3B-488A-85F0-1C34BF761AE9 Q39998122-79D8C9DA-39A0-4C26-917F-D27B8D1FE948 Q40842217-F9559996-BB5D-44AF-8EC8-0C50118B7166 Q41499639-1A3A9C5F-FB2A-48DC-9001-70E92294B261 Q41933030-BEC00918-A9C2-43D7-9F31-55496244BFD4

P2860

Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies

http://www.wikidata.org/entity/Q28287237

description

1998 nî lūn-bûn

@nan

1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Immunoelectron-microscopic dem ...... d in dementia with Lewy bodies

@ast

Immunoelectron-microscopic dem ...... d in dementia with Lewy bodies

@en

Immunoelectron-microscopic dem ...... d in dementia with Lewy bodies

@nl

type

label

Immunoelectron-microscopic dem ...... d in dementia with Lewy bodies

@ast

Immunoelectron-microscopic dem ...... d in dementia with Lewy bodies

@en

Immunoelectron-microscopic dem ...... d in dementia with Lewy bodies

@nl

altLabel

Immunoelectron-microscopic dem ...... d in dementia with Lewy bodies

@en

prefLabel

Immunoelectron-microscopic dem ...... d in dementia with Lewy bodies

@ast

Immunoelectron-microscopic dem ...... d in dementia with Lewy bodies

@en

Immunoelectron-microscopic dem ...... d in dementia with Lewy bodies

@nl

P1433

Q28287237-F61DB2A1-2EEC-40F0-985F-136146A4B3CD

P1476

Q28287237-8D5028C9-6E5D-48F4-8836-E8A91081F569

P2093

Q28287237-16A89C73-63F0-451A-84A4-DB4F6A6E34DD

Q28287237-1BEE8D1B-8363-40D6-8B7F-4A00CF7C1522

Q28287237-1E453718-76C4-468C-AD81-AC30A9D9F10C

Q28287237-72A9FFB7-D136-4798-8540-5FBF05D097A7

Q28287237-D1B4D76A-E7E0-4289-8FC8-C25BF337B788

Q28287237-D890B0A4-E3CE-4146-9A75-67951249D972

Q28287237-DA827DC2-CAD8-4ECB-A15A-65E704EE2D6C

P304

Q28287237-D78DF262-A27E-4C74-B77B-8AF0EDE1BE7D

P31

Q28287237-05961E7E-1084-4C71-B161-FC7E10767097

P3181

Q28287237-47F0B605-83CD-48DB-8444-0FD7AFC9241B

P356

Q28287237-F0B4D6E9-F744-4878-93D0-EEE31EE33A20

P407

Q28287237-E38FD37C-73BB-4C14-A5C9-453E791C7453

P433

Q28287237-76F220DA-CD25-4455-B002-7F8FD8715E61

P478

Q28287237-A8CDB6C7-80A0-40EC-818F-A9980D136358

P577

Q28287237-7A4A9BD0-F21B-46F2-9EBF-E213D127D73F

P698

Q28287237-5AC971D7-D925-4C4E-87A8-F9510262A973

P921

Q28287237-5C628688-3C35-49C9-B235-C0107E890F10

Q28287237-CA4C3272-8252-4998-B8EE-547754F19CFA

P3181

P356

S0006-8993(98)00734-3

P1433

P1476

Immunoelectron-microscopic dem ...... d in dementia with Lewy bodies

@en

P2093

H Tonozuka-Uehara

http://www.w3.org/2001/XMLSchema#string

K Arima

http://www.w3.org/2001/XMLSchema#string

K Uéda

http://www.w3.org/2001/XMLSchema#string

M Kawai

http://www.w3.org/2001/XMLSchema#string

N Sunohara

http://www.w3.org/2001/XMLSchema#string

S Hirai

http://www.w3.org/2001/XMLSchema#string

Y Izumiyama

http://www.w3.org/2001/XMLSchema#string

P304

93-100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3503496

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/S0006-8993(98)00734-3

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

808

http://www.w3.org/2001/XMLSchema#string

P577

1998-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9795161

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease